Phase Ib trial of taladegib in solid tumours

Trial Profile

Phase Ib trial of taladegib in solid tumours

Phase of Trial: Phase I

Latest Information Update: 10 May 2016

At a glance

  • Drugs Taladegib (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 10 May 2016 According to an Ignyta media release, company is expected to initiate this trial in the third quarter of 2016.
    • 13 Jan 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top